Horan Securities, Inc. Astrazeneca PLC Transaction History

Horan Securities, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$63.15 - $71.6 $2,210 - $2,506	-35 Reduced 8.16%	394 $27,000
Q4 2022 Jan 17, 2023	BUY	$54.21 - $70.44 $1,897 - $2,465	35 Added 8.88%	429 $0
Q2 2022 Jul 19, 2022	SELL	$59.26 - $71.14 $2,963 - $3,557	-50 Reduced 11.26%	394 $26,000
Q4 2021 Feb 09, 2022	BUY	$54.02 - $63.83 $5,131 - $6,063	95 Added 27.22%	444 $26,000
Q2 2021 Aug 05, 2021	SELL	$48.42 - $60.18 $6,536 - $8,124	-135 Reduced 27.89%	349 $21,000
Q4 2020 Feb 05, 2021	BUY	$48.52 - $58.02 $13,100 - $15,665	270 Added 126.17%	484 $24,000
Q1 2020 May 05, 2020	BUY	$37.79 - $51.33 $8,087 - $10,984	214 New	214 $10,000
Q4 2019 Feb 05, 2020	SELL	$42.46 - $50.46 $9,086 - $10,798	-214 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$34.55 - $37.05 $7,393 - $7,928	214 New	214 $8,000

1,339

478M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $224B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.